Ureaplasma urealyticum destructive septic arthritis in a patient with systemic lupus erythematosus after rituximab therapy

Joint Bone Spine. 2011 May;78(3):323-4. doi: 10.1016/j.jbspin.2010.11.010. Epub 2010 Dec 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Arthritis, Infectious / drug therapy
  • Arthritis, Infectious / immunology
  • Arthritis, Infectious / microbiology*
  • Doxycycline / therapeutic use
  • Humans
  • Immunocompromised Host
  • Immunologic Factors / adverse effects*
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / drug therapy
  • Magnetic Resonance Imaging
  • Male
  • Rituximab
  • Treatment Outcome
  • Ureaplasma Infections / complications*
  • Ureaplasma Infections / drug therapy
  • Ureaplasma Infections / immunology
  • Ureaplasma urealyticum* / isolation & purification
  • Ureaplasma urealyticum* / physiology
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab
  • Doxycycline